Our Recommendations
- Pièce de communication : Tests de diagnostic disponibles dans le commerce (2021)
- Nota de Comunicação: Testes diagnósticos comercialmente disponíveis (2021)
- Schistosomiasis and Female Genital Schistosomiasis (FGS): a booklet for educators (2022)
- Practical and Precision Assessment Manual for Schistosomiasis (2024)
- WHO guideline on control and elimination of human schistosomiasis (2022)
New Publications
- Review of 2022 World Health Organization guidelines on the control and elimination of schistosomiasis (2022)
- Prevalence of Schistosoma mansoni, soil-transmitted helminths and intestinal protozoa in orphans and street children in Mwanza city, Northern Tanzania (2023)
- Schistosomiasis and soil-transmitted helminthiases: progress report, 2023 (2024)
- Diagnostics Collection (2025)
- The new WHO guideline for control and elimination of human schistosomiasis: implications for the Schistosomiasis Elimination Programme in Nigeria (2022)
Filter
130
Featured
Recommendations
12
New Publications
2
Language
Document type
Studies & Reports
40
Guidelines
28
Resource Platforms
19
Fact sheets
14
Manuals
7
Infographics
6
Dashboards/Maps
5
Videos
4
Brochures
3
Training Material
2
Strategic & Response Plan
2
Countries / Regions
Tanzania
11
Global
7
South Africa
3
Philippines
2
Southern Africa
2
Uganda
2
Kenya
1
Nigeria
1
Malawi
1
Zimbabwe
1
Mozambique
1
Asia
1
West and Central Africa
1
East and Southern Africa
1
Brazil
1
Sudan
1
Angola
1
Chad
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Studies & Reports
15
Schistosomiasis
6
Capacity Building
3
Community Health
2
Vector Control
1
Guidelines
1
Women & Child Health
1
Information, Education and Communication (IEC)
1
Statistics
1
Other
1
Parasitology
1
Toolboxes
Studies & Reports
39
Capacity Building & Resources
37
Clinical Aspects & Diagnostics
34
Statistics & Facts
20
Information & Education Material (IEC)
19
Prevention & Control
15
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field application rates of new molluscicide products for control of schistosomiasis.
Lancet Infectious Diseases Volume 22, Issue 11e327-e335.
In February, 2022, WHO published new guidelines with six recommendations to update the global public health strategy against schistosomiasis, including expansion of preventive chemotherapy eligibility from the predominant group of school-age...
Infection 2023 Oct;51(5):1399-1406. doi: 10.1007/s15010-023-01999-9. Epub 2023 Feb 20.
The results indicate a significantly higher rate of infections with S. mansoni in street children compared with orphans. This might be explained by the lack of access to adequate sanitation for street children ...
Weekly epidemiological record WER9948-707-717
In English and French
The Global Schistosomiasis Alliance Diagnostic Workstream has developed a communications piece listing all commercially available diagnostics for schistosomiasis
2nd edition
The Global Schistosomiasis Alliance Diagnostic Workstream has developed a communications piece listing all commercially available diagnostics for schistosomiasis
The Global Schistosomiasis Alliance Diagnostic Workstream has developed a communications piece listing all commercially available diagnostics for schistosomiasis
The Global Schistosomiasis Alliance Diagnostic Workstream has developed a communications piece listing all commercially available diagnostics for schistosomiasis
Highlighted Diagnostic Resources on Schistosomiasis
2nd edition. The purpose of this document is to provide a generic model that can be used for risk assessment of larviciding and mollusciciding; it aims to harmonize the risk assessment of such pesticides for public health use. The assessment considers both adults and children (all age groups) as we...
Infectious Diseases of Poverty (2022) 11:111; With some 134,073,166 people living in endemic communities at risk of infection, Nigeria is the most endemic country in Africa and requires preventive chemotherapy (PC) for a total of 26.3 million persons. The National Schistosomiasis Elimination Program...
DPDx Life Cycle Graphic
Schistosoma haematobium] [Schistosoma intercalatum] [Schistosoma japonicum] [Schistosoma mansoni] [Schistosoma mekongi]
Schistosomiases are acute or chronic visceral parasitic diseases due to 5 species of trematodes (schistosomes). The three main species infecting humans are Schistosoma haematobium, Schistosoma mansoni and Schistosoma japonicum. Schistosoma mekongi and Schistosoma intercalatum have a more limited dis...
Schistosomiasis, also known as Bilharzia, is an infection caused by a parasitic worm that lives in fresh water in subtropical and tropical regions. Schistosomiasis is second only to malaria as the most devastating parasitic disease. The parasites that cause schistosomiasis live in certain types of f...
Trop. Med. Infect. Dis. 2019, 4, 40; Schistosomiasis is an infectious disease caused by helminth parasites of the genus Schistosoma. Worldwide, an estimated 250 million people are infected with these parasites with the majority of cases occurring in sub-Saharan Africa. Within Asia, three species of ...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
La schistosomiase est une parasitose aiguë et chronique provoquée par des vers (trématodes) du genre Schistosoma. Selon les estimations, au moins 251,4 millions de personnes avaient besoin d’un traitement préventif en 2021. Le traitement préventif, qui devrait être renouvelé pendant un cert...
